Washington HB 2565: Concerning drug and gene therapy payment for medicaid managed care organizations.

Status: By resolution, returned to House Rules Committee for third reading. (as of 2018-03-08)

State: Washington · Session: 2017-2018 · Bill: HB 2565

Subjects: DRUGS, HEALTH CARE, PHARMACIES AND PHARMACISTS, PUBLIC ASSISTANCE, HEALTH CARE AUTHORITY

Sponsors: Schmick

View Washington HB 2565 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.